JAC Advance Access published online on October 21, 2004
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh451
© 2004 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Internal Medicine, Centre Hospitalier Jolimont-Lobbes, rue Ferrer 159, B-7100 Haine-Saint-Paul, Belgium; Department of Internal Medicine, Centre Hospitalier Universitaire du Sart Tilman, Bâtiment B 35 Sart-Tilman, B-4000 Liège, Belgium
* To whom correspondence should be addressed.
Correspondence
Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections
2 Department of Microbiology, Centre Hospitalier Jolimont-Lobbes, rue Ferrer 159, B-7100 Haine-Saint-Paul, Belgium
3 Department of Internal Medicine, Centre Hospitalier Jolimont-Lobbes, rue Ferrer 159, B-7100 Haine-Saint-Paul, Belgium
Frédéric Frippiat, E-mail: f.frippiat{at}chu.ulg.ac.be
This article has no Abstract.
Keywords:
moxifloxacin; rifampicin; bone infections; joint infections.
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in J. Antimicrob. Chemother.:
- Treatment of Gram-positive bone and joint infection: authors' response
- Elizabeth S. R. Darley and Alasdair P. MacGowan
J. Antimicrob. Chemother. 2004 10.1093/jac/dkh461.[Abstract]
This article has been cited by other articles:
![]() |
O. Grossi, J. Caillon, C. Arvieux, C. Jacqueline, D. Bugnon, G. Potel, and A. Hamel In Vivo Efficacy of Moxifloxacin Compared with Cloxacillin and Vancomycin in a Staphylococcus aureus Rabbit Arthritis Experimental Model Antimicrob. Agents Chemother., September 1, 2007; 51(9): 3401 - 3403. [Abstract] [Full Text] [PDF] |
||||
